Importantly, a subset of ANK2 variants associated with cardiac arrhythmias failed to rescue the metabolic defects in Ank2−/− adipocytes (117), calling to attention additional cardiovascular risk considerations for individuals with known ANK2 cardiac arrhythmia variants. This evidence concerns the gene ANK2 and chronic obstructive pulmonary disease.